We review these patents for validity and of course there's a lot of incentives on the other side to press the patent to the bursting point,

This decision could have been reached much earlier, and we could have been well into the proceeding that they're now just starting.

We are disappointed that the FDA did not approve our application,

While we believe that a delay is not justified, we will use the opportunity presented by the FDA proceedings to continue to press for approval of Plan B as an OTC/Rx Product.

We want to establish ourselves as the leading company in women's health care.

we will ... continue to press for approval of Plan B as an over-the-counter/ prescription product.